Ibogaine for Veterans with PTSD: What the Stanford Study Found

Ibogaine is one of the most closely watched treatments for veterans with post-traumatic stress disorder (PTSD). In a 2024 Stanford University study published in Nature Medicine, 30 U.S. special operations veterans treated with ibogaine and magnesium at a clinic in Mexico reported an average 88% reduction in PTSD symptoms, 87% in depression and 81% in anxiety one month later. The study was small and had no control group, so ibogaine is not a proven cure, but it has pushed states like Texas and Arizona to fund clinical trials.

Key takeaways

• Stanford researchers followed 30 special operations veterans, most with PTSD and a history of blast exposure and traumatic brain injury.
• One month after a single ibogaine treatment, average disability scores went from 30.2 (mild to moderate disability) to 5.1 (no disability).
• There were no serious adverse events or heart complications in the study, where ibogaine was given with magnesium and under medical monitoring.
• Ibogaine is not approved by the FDA and is illegal in the United States, so veterans travel to medically supervised clinics in Mexico.
• In 2025, Texas approved $50 million and Arizona $5 million in public funds for ibogaine research focused on veterans and first responders.

Why veterans are turning to ibogaine

PTSD affects a large share of combat veterans, and many live with it alongside depression, anxiety, alcohol misuse, chronic pain and the effects of repeated head trauma. Standard treatments such as prolonged exposure therapy, cognitive processing therapy and SSRIs help many people, but a significant number do not respond, drop out, or improve only partially.

Veteran-led nonprofits such as VETS (Veterans Exploring Treatment Solutions), founded by former Navy SEAL Marcus Capone and his wife Amber after his own ibogaine treatment, began helping special operations veterans travel to clinics in Mexico. Their stories, told in TIME and in the documentary In Waves and War, caught the attention of researchers at Stanford.

What the Stanford study found

The study, led by psychiatrist Nolan Williams, MD, was published in Nature Medicine in January 2024. Researchers evaluated 30 male special operations veterans before treatment, immediately after and one month later. Of them, 23 met criteria for PTSD, 15 for alcohol use disorder and 14 for an anxiety disorder; 19 had experienced suicidal thoughts and 7 had attempted suicide.

Participants received oral ibogaine together with intravenous magnesium, which was used to protect the heart. One month after treatment, the average results were:

Formal cognitive testing also showed better concentration, information processing, memory and impulse control. "No other drug has ever been able to alleviate the functional and neuropsychiatric symptoms of traumatic brain injury," Dr. Williams said. "The results are dramatic, and we intend to study this compound further."

The only side effects reported were common, temporary ones such as headache and nausea. No participant had the heart rhythm problems that have occasionally been linked to ibogaine.

What the study does not prove

It is important to read these results carefully:

• There was no placebo or control group. Some improvement may come from expectation, the retreat setting or simply the passage of time.
• The sample was small and specific: 30 men, all special operations veterans, who chose to travel for treatment.
• The follow-up was one month. Longer-term data are still limited.

That is why the next step is randomized controlled trials. In 2025, Texas approved $50 million for FDA-oriented ibogaine trials, with veterans and first responders as a priority, and Arizona approved $5 million for research. Until those trials report, ibogaine for PTSD should be considered promising but not proven.

How ibogaine may help with trauma

Researchers are still working out the mechanism. Ibogaine acts on several brain systems at once, and its long-acting metabolite, noribogaine, stays in the body for days. Animal research suggests ibogaine increases neurotrophic factors involved in neuroplasticity. In a 2025 follow-up in Nature Mental Health, the Stanford team found that veterans whose PTSD improved showed lower complexity of cortical brain activity, and those whose executive function improved showed more theta rhythms.

Many veterans also describe the experience itself as important: a long, dream-like review of memories that lets them look at traumatic events with less fear. We explain related brain research in ibogaine and traumatic brain injury.

Is ibogaine safe for veterans?

Ibogaine's main risk is cardiac. It temporarily prolongs the heart's QT interval, which can trigger dangerous arrhythmias in people with heart disease, electrolyte problems or certain medications. Deaths have been reported, mostly in unsupervised settings or in people with undetected risk factors.

Veterans have additional factors to screen for: medications for PTSD, sleep and pain (many of which affect the QT interval), heavy alcohol use and benzodiazepines, which need a separate medical detox first. A responsible clinic should require an EKG, blood tests and a full medication review before accepting anyone. Read more in ibogaine side effects and heart safety.

Who may be a candidate

• Veterans and first responders with PTSD, depression or anxiety that has not responded well to conventional treatment.
• People with a normal EKG and no significant heart disease after a full cardiac screening.
• People who are stable enough to travel and willing to commit to aftercare and integration.

People with structural heart disease, a prolonged QT interval, active psychosis or bipolar I disorder, or who cannot safely stop certain medications, are generally not candidates.

Treatment for veterans at Ibogaine Center Cancún

Our 7-day program in Cancun includes a full medical evaluation before arrival, a cardiologist on site during treatment, continuous EKG telemetry, one-to-one ACLS critical care nursing and a 90-day aftercare plan. We accept a maximum of six patients at a time in private suites. The program costs US$10,000, and you can see the schedule in what to expect during 7 days.

See how treatment works, what is included and who can apply in our ibogaine program for PTSD and trauma.

Frequently asked questions

Does ibogaine cure PTSD?

No. Ibogaine is not a cure and is not approved for PTSD. In the Stanford study, veterans showed large improvements one month after treatment, but the study had no control group. Controlled trials are under way to confirm these results.

Is ibogaine legal for veterans in the United States?

No. Ibogaine is a Schedule I substance in the United States. Veterans who receive it travel to countries such as Mexico, where it is not a controlled substance and medically supervised clinics operate.

Does the VA cover ibogaine treatment?

No. The VA does not cover ibogaine because it is not FDA-approved. Some veteran nonprofits offer grants or scholarships to help with the cost of treatment abroad.

How long do the effects last?

The Stanford study measured results at one month. Patients and clinicians report that the benefits are more lasting when treatment is followed by therapy, integration and lifestyle changes, but long-term controlled data are still limited.

Can I take ibogaine if I take antidepressants or sleep medication?

Not without a medical review. Many psychiatric and sleep medications interact with ibogaine or affect the heart. Our medical team reviews every medication and, when needed, plans a safe tapering with your doctor before treatment.

References

• Cherian, K. N. et al. "Magnesium–ibogaine therapy in veterans with traumatic brain injuries." Nature Medicine, 2024.
• Stanford Medicine News Center. "Psychoactive drug ibogaine effectively treats traumatic brain injury in special ops military vets", January 2024.
• Lissemore, J. I. et al. "Magnesium–ibogaine therapy effects on cortical oscillations and neural complexity in veterans with traumatic brain injury." Nature Mental Health, 2025. DOI

Are you a veteran or first responder considering ibogaine? Start with a confidential medical evaluation with our team. Request your evaluation.